title: Prescribing bevacizumab off-label contravenes GMC advice.
authors.forename: Graham
authors.initials: G
authors.lastname: Kyle
mesh_terms: D020533:Angiogenesis Inhibitors / Q000191:economics*; D000911:Antibodies, Monoclonal / Q000191:economics*; D061067:Antibodies, Monoclonal, Humanized / Q000191:economics*; D000068258:Bevacizumab; D006801:Humans; D000069579:Ranibizumab; D057135:Wet Macular Degeneration / Q000191:economics*
chemical_list: D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D000069579:Ranibizumab